经颈内静脉肝内门体分流术治疗门静脉高压症_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 张晓武 ,  李肖

四川大学华西医院介入治疗科（四川成都 610041）;

Corresponding author：

李肖, Email: simonlixiao@263.net

Keywords：

DOI：

10.7507/1007-9424.20150343

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 张晓武, 李肖. 经颈内静脉肝内门体分流术治疗门静脉高压症. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2015, 22(11): 1310-1313. doi: 10.7507/1007-9424.20150343 Copy

1.	Richter GM, Palmaz JC, Nöldge G, et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method. Radiologe, 1989, 29(8):406-411.
2.	Richter GM, Noeldge G, Palmaz JC, et al. Transjugular intrahepatic portacaval stent shunt:preliminary clinical results. Radiology, 1990, 174(3 Pt 2):1027-1030.
3.	Lau CT, Scott M, Stavropoulos SW, et al. Dacron-covered stentgrafts in transjugular intrahepatic portosystemic shunts:initial experience. Radiology, 2005, 236(2):725-729.
4.	Angermayr B, Cejna M, Koenig F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt:ePTFEcovered stentgrafts versus bare stents. Hepatology, 2003, 38(4):1043-1050.
5.	Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt:a randomized controlled trial. J Hepatol, 2014, 60(5):962-968.
6.	Sommer CM, Gockner TL, Stampfl U, et al. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt:bare metal stents (BMS) versus viatorr stent-grafts (VSG). Eur J Radiol, 2012, 81(9):2273-2280.
7.	Boyer TD, Haskal ZJ; American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension:update 2009. Hepatology, 2010, 51(1):306.
8.	de Franchis R, Baveno V Faculty. Revising consensus in portal hypertension:report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol, 2010, 53(4):762-768.
9.	Roessle M. TIPS:25 years later. J Hepatol, 2013, 59(5):1081-1093.
10.	Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients:meta-analysis update. J Clin Gastroenterol, 2008, 42(5):507-516.
11.	Luca A, D'Amico G, La Galla R, et al. TIPS for prevention of recurrent bleeding in patients with cirrhosis:meta-analysis of randomized clinical trials. Radiology, 212(2):411-421.
12.	Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy:randomized trials for secondary prophylaxis of variceal bleeding:an updated meta-analysis. Scand J Gastroenterol, 2002, 37(3):249-252.
13.	Rosemurgy AS, Serafini FM, Zweibel BR, et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt:extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg, 2001, 4(6):589-597.
14.	Henderson JM, Boyer TD, Kutner MH, et al. Distal splenorenal shunt versus transjugular intrahlepatic portal systematic shunt for variceal bleeding:a randomized trial. Gastroenterology, 2006, 130(6):1643-1651.
15.	Boyer TD, Henderson JM, Heerey AM, et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol, 2008, 48(3):407-414.
16.	Monescillo A, Martínez-Lagares F, Ruiz-Del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology, 2004, 40(4):793-801.
17.	García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med, 2010, 362(25):2370-2379.
18.	García-Pagán JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding:results of a post-RCT surveillance study. J Hepatol, 2013, 58(1):45-50.
19.	Ginès P, Titó L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology, 1988, 94(6):1493-1502.
20.	Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax:a critical update. Gut, 2010, 59(7):988-1000.
21.	Russo MW, Sood A, Jacobson IM, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites:An analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol, 2003, 98(11):2521-2527.
22.	Salerno F, Cammà C, Enea M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis of individual patient data. Gastroenterology, 2007, 133(3):825-834.
23.	Gerbes AL, Sauerbruch T, Dathe K. Method report:German S3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome". Z Gastroenterol, 2011, 49(6):780-787.
24.	Michl P, Gülberg V, Bilzer M, et al. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites:Effects in patients with organic or functional renal failure. Scand J Gastroenterol, 2000, 35(6):654-658.
25.	Brensing KA, Textor J, Perz J, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome:a phaseⅡstudy. Gut, 2000, 47(2):288-295.
26.	Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology, 2004, 40(1):55-64.
27.	Testino G, Ferro C, Sumberaz A, et al. Type-2 hepatorenal syndrome and refractory ascites:Role of transjugular intrahepatic portosysternic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology, 2003, 50(54):1753-1755.
28.	Tsauo J, Weng NN, Ma HY, et al. Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome:a systemic literature review. J Vasc Interv Radiol, 2015, 26(9):1266-1271.
29.	Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology, 1997, 25(6):1366-1369.
30.	Jeffries MA, Kazanjian S, Wilson M, et al. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg, 1998, 4(5):416-423.
31.	Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol, 2002, 13(4):385-390.
32.	Wilputte JY, Goffette P, Zech F, et al. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction:a long-term study in 28 patients. Acta Gastroenterol Belg, 2007, 70(1):6-10.
33.	Dhanasekaran R, West JK, Gonzales PC, et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol, 2010, 105(3):635-641.
34.	Rössle M, Olschewski M, Siegerstetter V, et al. The Budd-Chiari syndrome:outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery, 2004, 135(4):394-403.
35.	Valla DC. Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut, 2008, 57(10):1469-1478.
36.	Garcia-Pagán JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome:long-term results and prognostics factors in 124 patients. Gastroenterology, 2008, 135(3):808-815.
37.	Luca A, Caruso S, Milazzo M, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology, 2012, 265(1):124-132.
38.	Werner KT, Sando S, Carey EJ, et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation:outcome of anticoagulation. Dig Dis Sci, 2013, 58(6):1776-1780.
39.	Chen H, Qi X, He C, et al. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res, 2013, 131(2):173-177.
40.	Luca A, Miraglia R, Caruso S, et al. Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut, 2011, 60(6):846-852.
41.	Luo XE, Wang Z, Tsauo J, et al. Advanced cirrhosis combined with portal vein thrombosis:a randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding. Radiology, 2015, 276(1):286-293.

1. Richter GM, Palmaz JC, Nöldge G, et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method. Radiologe, 1989, 29(8):406-411.
2. Richter GM, Noeldge G, Palmaz JC, et al. Transjugular intrahepatic portacaval stent shunt:preliminary clinical results. Radiology, 1990, 174(3 Pt 2):1027-1030.
3. Lau CT, Scott M, Stavropoulos SW, et al. Dacron-covered stentgrafts in transjugular intrahepatic portosystemic shunts:initial experience. Radiology, 2005, 236(2):725-729.
4. Angermayr B, Cejna M, Koenig F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt:ePTFEcovered stentgrafts versus bare stents. Hepatology, 2003, 38(4):1043-1050.
5. Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt:a randomized controlled trial. J Hepatol, 2014, 60(5):962-968.
6. Sommer CM, Gockner TL, Stampfl U, et al. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt:bare metal stents (BMS) versus viatorr stent-grafts (VSG). Eur J Radiol, 2012, 81(9):2273-2280.
7. Boyer TD, Haskal ZJ; American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension:update 2009. Hepatology, 2010, 51(1):306.
8. de Franchis R, Baveno V Faculty. Revising consensus in portal hypertension:report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol, 2010, 53(4):762-768.
9. Roessle M. TIPS:25 years later. J Hepatol, 2013, 59(5):1081-1093.
10. Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients:meta-analysis update. J Clin Gastroenterol, 2008, 42(5):507-516.
11. Luca A, D'Amico G, La Galla R, et al. TIPS for prevention of recurrent bleeding in patients with cirrhosis:meta-analysis of randomized clinical trials. Radiology, 212(2):411-421.
12. Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy:randomized trials for secondary prophylaxis of variceal bleeding:an updated meta-analysis. Scand J Gastroenterol, 2002, 37(3):249-252.
13. Rosemurgy AS, Serafini FM, Zweibel BR, et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt:extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg, 2001, 4(6):589-597.
14. Henderson JM, Boyer TD, Kutner MH, et al. Distal splenorenal shunt versus transjugular intrahlepatic portal systematic shunt for variceal bleeding:a randomized trial. Gastroenterology, 2006, 130(6):1643-1651.
15. Boyer TD, Henderson JM, Heerey AM, et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol, 2008, 48(3):407-414.
16. Monescillo A, Martínez-Lagares F, Ruiz-Del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology, 2004, 40(4):793-801.
17. García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med, 2010, 362(25):2370-2379.
18. García-Pagán JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding:results of a post-RCT surveillance study. J Hepatol, 2013, 58(1):45-50.
19. Ginès P, Titó L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology, 1988, 94(6):1493-1502.
20. Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax:a critical update. Gut, 2010, 59(7):988-1000.
21. Russo MW, Sood A, Jacobson IM, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites:An analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol, 2003, 98(11):2521-2527.
22. Salerno F, Cammà C, Enea M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis of individual patient data. Gastroenterology, 2007, 133(3):825-834.
23. Gerbes AL, Sauerbruch T, Dathe K. Method report:German S3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome". Z Gastroenterol, 2011, 49(6):780-787.
24. Michl P, Gülberg V, Bilzer M, et al. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites:Effects in patients with organic or functional renal failure. Scand J Gastroenterol, 2000, 35(6):654-658.
25. Brensing KA, Textor J, Perz J, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome:a phaseⅡstudy. Gut, 2000, 47(2):288-295.
26. Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology, 2004, 40(1):55-64.
27. Testino G, Ferro C, Sumberaz A, et al. Type-2 hepatorenal syndrome and refractory ascites:Role of transjugular intrahepatic portosysternic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology, 2003, 50(54):1753-1755.
28. Tsauo J, Weng NN, Ma HY, et al. Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome:a systemic literature review. J Vasc Interv Radiol, 2015, 26(9):1266-1271.
29. Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology, 1997, 25(6):1366-1369.
30. Jeffries MA, Kazanjian S, Wilson M, et al. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg, 1998, 4(5):416-423.
31. Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol, 2002, 13(4):385-390.
32. Wilputte JY, Goffette P, Zech F, et al. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction:a long-term study in 28 patients. Acta Gastroenterol Belg, 2007, 70(1):6-10.
33. Dhanasekaran R, West JK, Gonzales PC, et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol, 2010, 105(3):635-641.
34. Rössle M, Olschewski M, Siegerstetter V, et al. The Budd-Chiari syndrome:outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery, 2004, 135(4):394-403.
35. Valla DC. Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut, 2008, 57(10):1469-1478.
36. Garcia-Pagán JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome:long-term results and prognostics factors in 124 patients. Gastroenterology, 2008, 135(3):808-815.
37. Luca A, Caruso S, Milazzo M, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology, 2012, 265(1):124-132.
38. Werner KT, Sando S, Carey EJ, et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation:outcome of anticoagulation. Dig Dis Sci, 2013, 58(6):1776-1780.
39. Chen H, Qi X, He C, et al. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res, 2013, 131(2):173-177.
40. Luca A, Miraglia R, Caruso S, et al. Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut, 2011, 60(6):846-852.
41. Luo XE, Wang Z, Tsauo J, et al. Advanced cirrhosis combined with portal vein thrombosis:a randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding. Radiology, 2015, 276(1):286-293.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

经颈内静脉肝内门体分流术治疗门静脉高压症

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content